BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37377680)

  • 1. Compliance and clinical efficacy of vaginal dilator after radiotherapy for cervical and endometrial malignancies.
    Tahseen R; Ahmed Y; Tariq M; Abrar S; Ali N
    Ecancermedicalscience; 2023; 17():1545. PubMed ID: 37377680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy?
    Brand AH; Do V; Stenlake A
    Int J Gynecol Cancer; 2012 Jun; 22(5):897-904. PubMed ID: 22552831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of vaginal dilator use on vaginal stenosis and sexual quality of life in women treated with adjuvant radiotherapy for endometrial cancer.
    Akbaba S; Oelmann-Avendano JT; Krug D; Arians N; Bostel T; Hoerner-Rieber J; Nicolay NH; Debus J; Lindel K; Foerster R
    Strahlenther Onkol; 2019 Oct; 195(10):902-912. PubMed ID: 30997541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors.
    Charatsi D; Vanakara P; Evaggelopoulou E; Simopoulou F; Korfias D; Daponte A; Kyrgias G; Tolia M
    Medicine (Baltimore); 2022 Jan; 101(4):e28705. PubMed ID: 35089231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.
    Stahl JM; Qian JM; Tien CJ; Carlson DJ; Chen Z; Ratner ES; Park HS; Damast S
    Support Care Cancer; 2019 Apr; 27(4):1425-1433. PubMed ID: 30187220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric Predictors of Radiation-Induced Vaginal Stenosis After Pelvic Radiation Therapy for Rectal and Anal Cancer.
    Son CH; Law E; Oh JH; Apte AP; Yang TJ; Riedel E; Wu AJ; Deasy JO; Goodman KA
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):548-54. PubMed ID: 25936810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer.
    Chen SW; Liang JA; Yang SN; Hung YC; Yeh LS; Shiau AC; Lin FJ
    Gynecol Oncol; 2004 Oct; 95(1):208-14. PubMed ID: 15385134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
    Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
    Small W; Erickson B; Kwakwa F
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study.
    Hanlon A; Small W; Strauss J; Lin LL; Hanisch L; Huang L; Bai J; Wells J; Bruner DW
    Cancer Nurs; 2018; 41(3):200-209. PubMed ID: 28437283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
    Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
    Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy.
    Law E; Kelvin JF; Thom B; Riedel E; Tom A; Carter J; Alektiar KM; Goodman KA
    Radiother Oncol; 2015 Jul; 116(1):149-55. PubMed ID: 26164775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.
    Bahng AY; Dagan A; Bruner DW; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):667-73. PubMed ID: 21300451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Psychological Outcomes of the Use of Vaginal Dilators After Gynaecological Brachytherapy: a Randomized Clinical Trial.
    Cerentini TM; Schlöttgen J; Viana da Rosa P; La Rosa VL; Vitale SG; Giampaolino P; Valenti G; Cianci S; Macagnan FE
    Adv Ther; 2019 Aug; 36(8):1936-1949. PubMed ID: 31209699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers.
    Kanemoto A; Sugita T; Ayukawa F; Takahashi K; Horiuchi A; Haino K; Kikuchi A
    Jpn J Radiol; 2022 Jun; 40(6):639-644. PubMed ID: 34851502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer.
    Foerster R; Schnetzke L; Bruckner T; Arians N; Rief H; Debus J; Lindel K
    Strahlenther Onkol; 2016 Dec; 192(12):895-904. PubMed ID: 27605238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy.
    Chapman CH; Cunha AJ; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2021; 20(3):536-542. PubMed ID: 33549517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.